SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Tricida shares are trading lower after the company received a Complete Response Letter from the FDA for its New Drug Application for Veverimer.

Benzinga · 08/24/2020 12:32